Abstract
Foamy viruses (FVs) are common apathogenic retroviruses readily spread by horizontal transmission in nonhuman primate and some other mammalian host populations. Primate FV infections have been known for half a century, i.e., 15 years before the definition of retroviruses and another 15 years before the detection of primate immune deficiency viruses. The emerging interest in human retroviruses
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Achong BG, Mansell PWA, Epstein MA, Clifford P (1971) An unusual virus in cul-tures from a human nasopharyngeal carcinoma. J Nail Cancer Inst 46:299–302
Aguzzi A (1993) The foamy virus family molecular biology, epidemiology and neu-ropathology. Biochim Biophys Acta 1155:124
Aguzzi A, Marino S, Tschopp R, Rethwilm A (1996) Regulation of expression and pathogenic potential of human foamy virus in vitro and in transgenic mice. Curr Top Microbiol Immunol 206:243–273
Bieniasz PD, Rethwilm A, Pitman R, Daniel MD, Chrystie I, McClure MO (1995a) A comparative study of higher primate foamy viruses, including a new virus from a gorilla. Virology 207:217–228
Bieniasz PD, Weiss RA, McClure MO (1995b) Cell cycle dependence of foamy retro-virus infection. J Virol 69: 7295–7299
Blewett EL, Black DH, Lerche NW, White G, Eberle R (2000) SFV infection in a baboon breeding colony. Virology 278:183–193
Bock M, Heinkelein M, Lindemann D, Rethwilm A (1998) Cells expressing the human foamyvirus (HFV) accessory bet protein are resistant to productive HFV superinfection. Virology 250:194–204
Bothe K, Aguzzi A, Lassmann H, Rethwilm A, Horak I (1991) Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science 253:555–557
Broussard SR, Comuzzie AG, Leighton KL, Leland MM, Whitehead EM, Allan JS (1997) Characterization of new simian foamy viruses from African nonhuman primates. Virology 237: 349–59
Brown P, Morreau-Dubois C, Gajdusek DC (1982) Persistent asymptomatic infection of the laboratory mouse by simian foamy virus type 6: a new model of retroviral latency. Arch Virol 71: 229–234
Callahan ME, Switzer WM, Matthews AL, Roberts BD, Heneine W, Folks TM, Sandstrom PA (1999) Persistent zoonotic infection of a human with a simian foamy virus in the absence of an intact orf-2 accessory gene. J Virol 73:9619–24
Cameron, KR, Birchall SM, Moses, MA (1978) Isolation of foamy virus from patient with dialysis encephalopathy. Lancet II:796
Carski T (1960) A fluorescent antibody study of the simian foamy agent. J Immunol 84: 426–433
Colas S, Bourge JF, Wybier J, Chelbi-Alix MK, Paul P, Emanoil-Ravier R (1995) Human foamy virus infection activates class I major histocompatibility complex antigen expression. J Gen Virol 76:661–667
Enders JF, Peebles TC (1954) Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med 86:277–286
Falcone V, Leupold J, Clotten J, Urbanyi E, Herchenroeder O, Spatz W, Volk B, Boehm N, Toniolo A, Neumann-Haefelin D, Schweizer M (1999a) Sites of simian foamy virus persistence in naturally infected African green monkeys: latent pro-virus is ubiquitous, whereas viral replication is restricted to the oral mucosa. Virology 257:7–14
Falcone V, Schweizer M, Toniolo A, Neumann-Haefelin D, Meyerhans A (1999b) Gamma interferon is a major suppressive factor produced by activated human peripheral blood lymphocytes that is able to inhibit foamy virus-induced cytopathic effects. J Virol 73:1724–1728
Feldman MD, Dunnick NR, Barry DW, Paerkman PD (1975) Isolation of foamy virus from rhesus, African green and cynomolgus monkey leukocytes. J Med Primatol 4:287–295
Felsenstein J (1989) PHYLIP (phylogeny inference package) version 3.2. Cladistics 5:164–166
Fleming WA, Clarke JK (1970) Fluorescence assay of foamy virus. J Gen Virol 6:277–284
Hahn H, Baunach G, Bräutigam S, Mergia A, Neumann-Haefelin D, Daniel MD, McClure M, Rethwilm A (1994) Reactivity of primate sera to foamy virus Gag and Bet proteins. J Gen Virol 75:2635–2644
Heneine W, Switzer WM, Sandstrom P, Brown J, Shanmugam V, Schable CA, Khan AS, Lerche NW, Schweizer M, Neumann-Haefelin D, Chapman LE, Folks, TM (1998) Identification of a human population infected with simian foamy virus. Nat Med 4:403–407
Hirata RK, Miller AD, Andrews RG, Russell DW (1996) Transduction of hematopoietic cells by foamy virus vectors. Blood 88:3654–61
Hirsch VM, Dapolito G, Goeken R, Campbell BJ (1995) Phylogeny and natural history of the primate lentiviruses, SIV and HIV. Curr Opin Genet Dev 5:798–806
Hooks JJ, Burns W, Hayashi K, Geis S, Notkins AL (1976) Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection. Infect Immun 14:1172–1178
Hooks JJ, Gibbs CJ, Chou R, Howk R, Lewis M, Gajdusek DC (1973) Isolation of a new simian foamy virus from a spider monkey brain culture. Infect Immun 8:804–813
Hooks JJ, Gibbs CJ, Cutchins EC, Rogers NG, Lampert P, Gajdusek DC (1972) Characterization and distribution of two new foamy viruses isolated from chimpanzees. Arch Ges Virusforsch 38:38–55
Hooks JJ, Gibbs CJ (1975) The foamy viruses. Bacteriol Rev 39:169–185
Hooks JJ, Detrick-Hooks B (1979) Simian foamy virus-induced immunosuppression in rabbits. J Gen Virol 44: 383–390
Howcroft TK, Strebel K, Martin MA, Singer DS (1993) Repression of MHC-1 gene promoter activity by two-exon tat of HIV. Science 260:1320–1322
Imrich H, Müller JG, Lindemann D, Heinkelein M, Rethwilm A (2003) Pathogenicity of Foamy Virus in arhymic mice. (Submitted)
Johnston PB (1961) A second immunological type of simian foamy virus: monkey throat infection and unmasking by both types. J Infect Dis 109:1–9
Johnston PB (1971) Taxonomic features of seven serotypes of simian and ape foamy viruses. Infect Immun 3:793–799
Johnston PB (1974) Studies on simian foamy viruses and syncytium-forming viruses of lower animals. Lab Anim Sci 24:159–166
Kralli A, Ge R, Graeven U, Ricciardi RP, Weinmann R (1992) Negative regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells via a retinoic acid response element. J Virol 66:6979–6988
Lecellier CH, Saïb A (2000) Foamy viruses: Between retroviruses and pararetrovirus-es. Virology 271:1–8
Linial M (2000) Why aren’t foamy viruses pathogenic? Trends Microbiol 289:284–289
Linial ML (1999) Foamy viruses are unconventional retroviruses. J Virol 73:1747–1755
McClure MO, Bieniasz PD, Schulz TF, Chrystie IL, Simpson G, Aguzzi A, Hoad JG, Cunningham A, Kirkwood J, Weiss RA (1994) Isolation of a new foamy retrovirus from orangutans. J Virol 68:7124–7130
McClure MO, Erlwein 0 (1995) Foamy viruses-pathogenic or therapeutic potential. Rev Med Virol 5: 229–237
Meiering CD, Linial ML (2001) Historical perspective of foamy virus epidemiology and infection. Clin Microbiol Rev 14:165–176
Mergia A, Chan S, Kolson DL, Goodenow MM, Ciccarone T (2001) The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and human PBLs. Virology 280:243–252
Mergia A, Leung NJ, Blackwell J (1996) Cell tropism of the simian foamy virus type 1 (SFV-1). J Med Primatol 25:2–7
Mikovits JA, Hoffman PM, Rethwilm A, Ruscetti FW (1996) In vitro infection of primary and retrovirus-infected human leukocytes by human foamy virus. J Virol 70: 2774–2780
Neumann-Haefelin D, Fleps U, Renne R, Schweizer M (1993) Foamy viruses. Intervirology 35:196–207
Neumann-Haefelin D, Rethwilm A, Bauer G, Gudat F, zur Hausen H (1983) Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells. Med Microbiol Immunol 172:75–86
Parks WP, Todaro GJ, Scolnick EM, Aaronson SA (1971) RNA dependent DNA poly-merase in primate syncytium-forming (foamy) viruses. Nature 229:258–260
Regad T, Saib A, Lallemand-Breitenbach V, Pandolfi PP, de Thé H, Chelbi-Mix MK (2001) PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J 20:3495–3505
Rhodes-Feuillette A, Lasneret J, Paulien S, Ogunkolade W, Périès J, Canivet M (1990) Effects of human recombinant alpha and gamma and that of highly purified natural beta interferons on simian spumavirinae prototype (simian foamy virus 1) multiplication in human cells. Res Virol 141:31–43
Rhodes-Feuillette A, Saal F, Lasnaret J, Dubouch P, Périès J (1979) Isolation and characterization of a new simian foamy virus serotype from lymphocytes of a Papio cynocephalus baboon. J Med Primatol 8:308–320
Rhodes-Feuillette A, Saal F, Lasneret J, Santillana-Hayat M, Périès J (1987) Studies on in vitro interferon induction capacity and interferon sensitivity of simian foamy viruses. Arch Virol 97:77–84
Rogers N, Basnight M, Gibbs GJ, Gajdusek DC (1967) Latent viruses in chimpanzees with experimental kuru. Nature 216:446–449
Rösener M, Hahn H, Kranz M, Heeney J, Rethwilm A (1996) Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis. J Med Virol 48:222–226
Rustigian R, Johnston P, Reihart, H (1955) Infection of monkey kidney tissue cultures with virus-like agents. Proc Soc Exp Biol Med 88:8–16
Sabile A, Rhodes-Feuillette A, Jaoui FZ, Tobaly-Tapiero J, Giron ML, Lasneret J, Périès J, Canivet M (1996) In vitro studies on interferon-inducing capacity and sensitivity to IFN of human foamy virus. Res Virol 147:29–37
Saib A, Koken HM, van der Spek P, Périès J, de Thé H (1995b) Involvement of a spliced and defective human foamy virus in the establishment of chronic infection. J Virol 69:5261–5268
Saib A, Neves M, Giron ML, Guillemin MC, Valla J, Périès J, Canivet M (1997) Longterm persistent infection of domestic rabbits by the human foamy virus. Virology 228:263–268
Saib A, Périès J, de Thé H (1995a) Recent insights into the biology of the human foamy virus. Trends Microbio1:173–178
Saib A, Périès J, de Thé H (1993) A defective human foamy provirus generated by pregenome splicing. EMBO J 12:4439–4444
Santillana-Hayat M, Rozain F, Bittoun P, Chopin-Robert C, Lasneret J, Périès J Canivet M (1993) Transient immunosuppressive effect induced in rabbits and mice by the human spumaretrovirus prototype HFV (human foamy virus). Res Virol 144:389–396
Sawada M, Suzumura A, Yoshida M, Marunouchi T (1990) Human T-cell leukemia virus type 1 transactivator induces class I major histocompatibility complex antigen expression in glial cells. J Virol 64:4002–4006
Schmidt M, Niewiesk S, Heeney J, Aguzzi A, Rethwilm A (1997) Mouse model to study the replication of primate foamy viruses. J Gen Virol 78: 1929–1933
Schweizer M, Corsten B, Neumann-Haefelin D (1988) Heterogeneity of primate foamy virus genomes. Arch Virol 99:125–134
Schweizer M, Falcone V, Gaenge J, Turek R, Neumann-Haefelin D (1997) Simian foamy virus isolated from an accidentally infected human individual. J Virol 71:4821–4824
Schweizer M, Fleps U, Jaeckle A, Renne R, Turek R, Neumann-Haefelin D (1993) Simian foamy virus type 3 (SFV-3) in latently infected Vero cells: Reactivation by demethylation of proviral DNA. Virology 192:663–666
Schweizer M, Neumann-Haefelin D (1995) Phylogenetic analysis of primate foamy viruses by comparison of pol sequences. Virology 207:577–582
Schweizer M, Schleer H, Pietrek M, Liegibel J, Falcone V, Neumann-Haefelin D (1999). Genetic stability of foamy viruses: long-term study in an African green monkey population. J Virol 73:9256–9265
Schweizer M, Turek R, Hahn H, Schliephake A, Netzer KO, Eder G, Reinhardt M, Rethwilm A, Neumann-Haefelin D (1995) Markers of foamy virus (FV) infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected FIT prevalence in man AIDS Res Hum Retrovir 11:161–170
Scolnick E, Rands E, Aaronson SA, Todaro GJ (1970) RNA-dependent DNA polymer-ase activity in five RNA viruses: Divalent cation requirements. Proc Natl Acad SCI USA 67:1789–1796
Stiles GE, Bittle JL, Cabasso UJ (1964) Comparison of simian foamy virus strains including a new serological type. Nature 201:1350–1351
Swack NS, Hsiung GD (1975) Pathogenesis of simian foamy virus infection in natural and experimental hosts. Infect Immun 12:470–474
von Laer D, Neumann-Haefelin D, Heeney JL, Schweizer M (1996) Lymphocytes are the major reservoir for foamy viruses in peripheral blood. Virology 221:240–244
Voss G, Nick S, Stahl-Hennig C, Ritter K, Hunsmann G (1992) Generation of macaque B-lymphoblastoid cell lines with simian Epstein-Barr-like viruses: transformation procedure, characterization of the cell lines and occurrence of simian foamy virus. J Virol Methods 39:185–195
Weiss RA (1988) Foamy retroviruses. A virus in search of a disease. Nature 333:497–498
Weiss RA (1996) Foamy viruses bubble on. Nature 380: 201
Westarp ME, Fuchs D, Bartmann P, Hoff-Jorgensen R, Clausen J, Wachter H, Kornhuber HH (1993) Amyotrophic lateral sclerosis: an enigmatic disease with B-cellular and anti-retroviral immune responses. Eur J Med 2:327–332
Wybier-Franqui J, Tobaly-Tapiero J, Coronel A, Giron ML, Chopin-Robert C, Périès J, Emanoil-Ravier R (1995) Human foamy virus DNA forms and expression in persistently infected Dami megakaryocytic cells. AIDS Res Hum Retrovir 11:829–36
Yu SF, Stone J, Linial ML (1996) Productive persistent infection of hematopoietic cells by human foamy virus. J Virol 70:1250–1254
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Falcone, V., Schweizer, M., Neumann-Haefelin, D. (2003). Replication of Primate Foamy Viruses in Natural and Experimental Hosts. In: Rethwilm, A. (eds) Foamy Viruses. Current Topics in Microbiology and Immunology, vol 277. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55701-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-55701-9_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62934-1
Online ISBN: 978-3-642-55701-9
eBook Packages: Springer Book Archive